Final Analysis of a Randomized Phase 1b Trial to Assess Sequencing of the E39 and E39' Vaccines to Optimize Long-Term Antitumor Immunity in Folate Binding Protein (FBP) Expressing Tumors

Journal of the American College of Surgeons - Netherlands
doi 10.1016/j.jamcollsurg.2017.07.030

Related search